Split designed to achieve compliance with Nasdaq minimum bid price requirements BOSTON, May 2, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) ("TransCode" or the "Company"), the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics,...
Read More Details
Finally We wish PressBee provided you with enough information of ( TransCode Therapeutics Announces 1-for-28 Reverse Stock Split )
Also on site :
- ‘This is murder': Family remembers victims killed in Austin fire as 4th body recovered
- SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, NVEE, SOAR, PLL on Behalf of Shareholders
- Ilona Maher Gets Invite to Dance With Coco Gauff and Aryna Sabalenka